Read More News | Center for Inquiry Yesterday morning, the U.S. Supreme Court unanimously rejected a challenge to the Food and Drug Administration’s initial approval of and ongoing ability to regulate the abortion drug mifepristone. The Court ruled that the plaintiffs, an organization of anti-abortion doctors called the Alliance for Hippocratic Medicine, “lack Article III standing to challenge FDA’s actions.” CFI General …